Synopsis Reduced reproduction extends lifespan of females in many animals. To test the effects of reproduction on storage of macronutrients, we block reproductive output in the lubber grasshopper by injecting RNAi against the precursor to egg-yolk protein, vitellogenin, in early adulthood. Controls were injected with either buffer or RNAi against the major storage protein in the hemolymph, hexamerin-90. Vitellogenin RNAi greatly reduced both levels of mRNA for vitellogenin and ovarian growth, in comparison to both controls. Fat body mass was increased upon vitellogenin RNAi, but concentrations of the three hexameric storage proteins from the hemolymph were not. Surprisingly, hemolymph vitellogenin levels were increased upon vitellogenin RNAi. Total reproductive protein (hemolymph vitellogenin plus ovarian vitellin) was unchanged by vitellogenin RNAi, as reproductive protein was diverted to the hemolymph. Similarly, the increased lipid storage upon vitellogenin RNAi was largely attributable to the reduction in lipid in the ovary, due to decreased ovarian growth. A BLAST search revealed that the 515 bp sequence of vitellogenin used for RNAi had three 11 bp regions identical to the vitellogenin receptor of the cockroach Leucophaea maderae. This suggests that our treatment, in addition to reducing levels of vitellogenin transcript, may have also blocked transport of vitellogenin from the hemolymph to the ovary. This would be consistent with halted ovarian growth simultaneous with high levels of vitellogenin in the hemolymph. Nonetheless, the accumulation of vitellogenin, instead of hexameric storage proteins, is inconsistent with a simple model of the trade-off between reproduction and storage. This was observed in young females; future studies will address whether investment of proteins may shift to the soma as individuals age. Overall, our results suggest that blockage of reproduction in young grasshoppers redirects lipids to storage and reproductive proteins to the hemolymph.
Introduction
Life-history trade-offs between reproduction and longevity are well conserved (Flatt 2011) . In particular, many animals with reduced reproduction also exhibit increased longevity and increased storage of lipids (Hansen et al. 2013) . For example, decreased reproduction, increased lifespan, and increased storage are seen in nematodes upon ablation of the germ-line cells (Goudeau et al. 2011) , fruit flies lacking full signaling for insulin-like peptides (Tatar et al. 2001) , and mice lacking the receptor for growth hormone (Masternak et al. 2012) . Hence, the broader trade-off between reproduction and longevity also apparently involves a trade-off between reproduction and storage. At the physiological level, individuals that are long-lived tend to divert investment of nutritional resources away from reproduction and toward somatic storage (e.g., Glazier 1999) . Here, we examine the differential investment of macronutrients between reproduction and storage after experimental reduction of reproduction via RNAi knockdown.
Measurement of reproductive investment and storage in an individual is a robust approach for analyzing physiological trade-offs. Our group has spent more than a decade studying the physiology of plasticity in reproductive timing and allocation in the Eastern lubber grasshopper, Romalea microptera (Hatle et al. 2003a) . These large insects lay clutches of 30-60 eggs each ($0.5-1.0 dry g) several times during their lifetime. For the first clutch, adult females that are fully fed become vitellogenic at approximately 10 days. Upon synthesis by the fat body, vitellogenin is released into the hemolymph, reaching maximum levels between 20 and 25 days (Hatle et al. 2001) . Concurrent high levels of juvenile hormone (JH) stimulate transcription of vitellogenin by the fat body and likely trigger uptake of circulating vitellogenin into the growing oocytes of the ovary Fei et al. 2005) . Slight modification of vitellogenin upon uptake into the oocytes yields vitellin granules, which constitute approximately 90% of the total protein found within the oocytes. Oviposition then occurs around 35-40 days (Hatle et al. 2001; Drewry et al. 2011) .
The effects of reproduction on lifespan are also well studied in lubber grasshoppers. Ovariectomy in adult females increases lifespan by approximately 20% . In older adults, ovariectomy also augments somatic storage, as fat body mass, hemolymph volume, and levels of hexameric storage proteins in the hemolymph (see below) are all doubled after approximately 75 days (Hatle et al. 2008 (Hatle et al. , 2013 Judd et al. 2011) . At the same time, ovariectomy does not block the production of vitellogenin by the fat body, but it cannot be sequestered into the ovary, so vitellogenin accumulates in the hemolymph (Hatle et al. 2003b) .
Hexameric storage proteins often are used to support key life-history events in insects, such as molting and reproduction (Telfer and Kunkel 1991; Burmester 1999) . The hexamerins are degraded during these vital events and the amino acids are used for multiple purposes. In lubber grasshoppers, three major hexamerins are synthesized by the fat body and secreted into the hemolymph. They are named based on their sizes of 90, 270, and 500 kDa when separated on native-gel electrophoresis. The 90 kDa storage protein (hexamerin-90) is classified as an arylphorin because it is rich in aromatic amino acids. It is the most abundant of the three hexamerins, constituting approximately 70% of the total storage protein. The maximum titer of hexamerin-90 is attained at approximately 20 days after adult molt, in the middle of the female's oviposition cycle (Hathaway et al. 2009 ). The importance of the three hexamerins in reproduction is illustrated by the fact that their collective maximum titer was a strong predictor (even better than vitellogenin) of the number of eggs produced in a clutch (Hatle et al. 2001) .
Here, we use RNAi post-transcriptional silencing of vitellogenin to address the physiological mechanisms underlying the trade-off between reproduction and storage. Vitellogenin has a conserved, central role in reproduction, and also in aging (Brandt et al. 2005) . Despite this, to our knowledge, knockdown of vitellogenin has been used only in nematode worms once (Murphy et al. 2003) and in honey bees' social organization extensively (Amdam 2010) . The role of vitellogenin in worker bees is very different from the role of vitellogenin in non-social insects. Worker bees are non-reproductive females dedicated first to nursing in the colony and then to foraging for the colony. Treatment of worker nurse bees with RNAi against vitellogenin results in accelerated progression to foraging, and decreased stress resistance, survival, and storage of nutrients. Hence, vitellogenin affects storage and survival in worker bees, but in the opposite direction to which reproduction affects storage and survival in other animals (Amdam 2010; Hansen et al. 2013) .
Based on previous observations on various model organisms (see Hansen et al. 2013 ) as well as ovariectomized lubber grasshoppers, we hypothesize that reduction of reproductive output through direct knockdown of vitellogenin mRNA will lead to an increase in somatic storage, which could have possible life-extending implications. In particular, we predict that RNAi of vitellogenin will halt ovarian growth, and as a result, lipids will be invested in the fat body and amino acids will be invested in hemolymph hexamerins.
Materials and methods

Experimental animals
Eastern Lubber grasshoppers were obtained as juveniles from the Ortega Farms population in Jacksonville, FL, USA, to test physiological effects of vitellogenin RNAi on reproduction and storage (Experiments 1 and 3) or from a colony maintained at Illinois State University to test effects of vitellogenin RNAi on clutch parameters (Experiment 2). Juveniles were reared communally on an ad libitum diet of Romaine lettuce daily and oatmeal occasionally. Upon molting into adulthood, virgin females were raised individually on lettuce only . They were serially assigned into three treatment groups: RNAi treatment for vitellogenin (Vg RNAi), RNAi treatment for the 90 kDa hexameric storage protein (Hex-90 RNAi) as control for RNAi effects on physiology, or buffer-injected control. Knockdown of Hex-90 was used as a control instead of a ''scramble'' dsRNA control because actually knocking down a transcript in the animal more closely simulates any off-target effects stimulated by a generalized ''RNAi response''.
dsRNA synthesis and injection
The dsRNA for injections was made according to Ambion's MEGAscript Õ RNAi Kit (Life Technologies, Grand Island, NY, USA). First, total RNA was extracted from fat body tissue of vitellogenic females (RiboPure TM Kit, Ambion, Life Technologies), then reverse transcribed to cDNA (iScript TM cDNA Synthesis Kit, Bio-Rad Laboratories, Hercules, CA, USA), and used to construct a DNA template for dsRNA synthesis.
To construct DNA templates, sequence-specific primers (see Table 1 for primers; see Supplementary Tables S1-S3 for the regions of the genes that were amplified) for vitellogenin and hexamerin-90 were designed using Primer3 software to select products of approximately 500 bp. The following quantitative polymerase chain reaction (qPCR) thermocycling parameters were used: 45 cycles of 95/52/728C for 45/60/45 s, respectively. Products from identical PCR reactions were sequenced by the Nevada Genomics Center to confirm the correct amplicon was produced. To convert the DNA to RNA, the transcription reactions followed the manufacturer's protocols except the reactions ran for 4 h with 8 mL of the qPCR product as template (rather than 1 mg as specified by the manufacturer's protocol).
For R. microptera vitellogenin, only 733 bp of the sequence are known. The 661 bp dsRNA against vitellogenin shares 98% identity with the 515 bp dsRNA (see Supplementary Table S1 ). Hence, the second set of primers serves as a second test that the product produced is from vitellogenin, but due to sequence overlap it does not check for possible annealing to other transcripts in the animal that may lead to non-target effects of RNAi.
Aliquots (5 mg in variable volumes) of dsRNA were stored at À208C and brought up to 30 mL using nuclease-free water or injection buffer (10 mM TrisHCl and 1 mM ethylenediaminetetraacetic acid) just prior to injection. At day 5, animals were injected with the dsRNA of respective treatments intraabdominally between the fifth and sixth sterna.
Experiment 1: physiological effects of vitellogenin RNAi on reproduction and storage
Design
Upon molting into adulthood, virgin females were serially assigned to one of three treatment groups (Vg RNAi, or Buffer) . Within these groups, animals were dissected at ages 12, 19, 26, and 33 days (AE1 day), with each age group containing seven to nine individuals.
Collection of data
At the time of dissection, hemolymph samples of 5 mL were collected and diluted into 250 mL of phosphate-buffered saline for quantification of vitellogenin and hexamerin protein levels (Hatle et al. 2008; Hathaway et al. 2009 ). Fat body tissues and ovaries were harvested and their wet masses were recorded . Approximately 50 mg of fat body tissue was stored in RNAlater Õ Solution (Ambion, Life Technologies) at À208C.
mRNA quantification
Total RNA was extracted from fat body tissue, stored in RNAlater Õ , and then converted to cDNA (as described above). Transcript abundance for vitellogenin and hexamerin-90 in the fat body was quantified (relative to b-actin) utilizing qPCR. The composition of the reactions was 10 mL of iQ TM SYBR Õ Green Supermix (Bio-Rad Laboratories), 1 mL (10 mM) each of sequence-specific forward and reverse primers, 1 mL Table 1 Primers used for PCR to produce templates for production of dsRNAs for RNAi Vitellogenin RNAi in young grasshoppers 933
of cDNA, and 7 mL of nuclease-free water. The vitellogenin primers were from Borst et al. (2000) , the hexamerin-90 primers were from Hathaway et al. (2009) , and the b-actin primers were from Fei et al. (2005) . The qPCR parameters were 958C for 1 min followed by 30 cycles of 95/50/728C each for 30 s (MJ Miniopticon, Bio-Rad Laboratories).
Quantification of hexamerin
From the hemolymph samples, hexamerins were quantified by native polyacrylamide gel electrophoresis. Samples were run on 4%!20% acrylamide-gradient gels (Bio-Rad Laboratories) at 48C for 12 h (Hathaway et al. 2009) , and then stained with Coomassie blue. Internal standards of bovine serum albumin (0.005%, 0.05%, and 0.5%) were run on each gel to establish a standard curve for the quantification of protein. Gels were imaged (Kodak Gel Logic 1500) and uploaded into ImageJ. The quantity of protein for each sample was determined by comparison to the standards of bovine serum albumin; this ImageJ analysis was conducted blind to the experimental treatments.
Quantification of vitellogenin protein
Vitellogenin in the hemolymph was quantified by enzyme-linked immunosorbent assay (ELISA) as in previous work Hatle et al. 2008) . Total reproductive protein was estimated from ovarian mass and hemolymph vitellogenin. In insects, the precursor to egg-yolk protein (viz., vitellogenin) is produced by the fat body, released to the hemolymph, and later sequestered into the ovary to become vitellin. Together, vitellin and vitellogenin make up the total reproductive protein of the individual. To estimate the amount of vitellin in each growing ovary, we started with the fact that a typical, full first clutch is 55 eggs and weighs about 4000 mg . From this ratio, we calculated the number of full-size egg equivalents that would be contained in each ovary. The average dry mass of an egg is 15 mg (Moehrlin and Juliano 1998) , and each egg is approximately 50% protein, 90% of which is vitellin. Hence, the number of egg equivalents was multiplied by 7 mg to estimate the total amount of vitellin. To estimate the total amount of vitellogenin, we used the estimate of hemolymph volume of 2.25 mL ($25% of the mass of a gravid female) for buffer-injected and hexamerin-90 RNAi animals. This estimate of hemolymph volume was increased 25% for vitellogenin RNAi animals, based on results of pilot experiments using 3 H-inulin as a volume marker (J. D. Hatle, unpublished data). The hemolymph volume was multiplied by the concentration of vitellogenin (Fig. 2) to obtain the estimate of total vitellogenin. Total reproductive protein is the sum of vitellin and vitellogenin.
Experiment 2: clutch parameters
To determine whether vitellogenin RNAi delayed oviposition or reduced the size of clutches, grasshoppers were administered dsRNA within 2 days after laying their first clutch. Injection treatments were the same as in Experiment 1 (Vg RNAi, Hex-90 RNAi, or Buffer) with an additional 661 bp dsRNA against vitellogenin (see Table 1 and Supplementary Table  S1 ) and included 7-10 individuals per treatment. The preparation and delivery of injections were performed the same as in Experiment 1.
Grasshoppers were tested for oviposition three times per week, on non-consecutive days. Upon laying, age of the female was recorded, number of eggs per clutch was counted, and the length of five representative eggs was measured .
Experiment 3: mass-specific, in vitro production of vitellogenin
To determine whether vitellogenin continued to be produced after administering vitellogenin RNAi, we measured the rate of production of vitellogenin in vitro at 19 and 26 days. These ages were selected because this is about the period of peak production of vitellogenin Hatle et al. 2005) . Injection treatments were the same composition and at the same developmental age as in Experiment 1.
Production of vitellogenin was measured according to previously described methods (Fei et al. 2005; Hatle et al. 2005) . Briefly, small sheets of fat body were incubated in 500 mL of modified Grace's medium for 2 h to rinse the tissue and release vitellogenin from damaged cells. This step was tested by poisoning some test wells with sodium azide; the rinse removes most but not all of the vitellogenin. After the 2 h rinse, the fat body was transferred to another well with identical Grace's medium for 4 h to measure the production of vitellogenin. At the end of the 4 h incubation, the fat body was removed and the medium was tested for vitellogenin by ELISA.
Statistics
All data were analyzed utilizing SAS statistical software (SAS Institute Inc, Cary, NC, USA) using twoway analyses of variance (ANOVAs) or multiple analyses of variance (MANOVAs) (injection and time as independent variables). 
Results
To verify the knockdown of gene expression in response to injections (applied at age 5 days), transcript levels both for vitellogenin and for hexamerin-90 relative to b-actin were quantified at ages 12, 19, 26, and 33 days after adult molt (Fig. 1) . The mRNA levels were significantly affected by injections (twoway MANOVA, Pillai's Trace F 4,78 ¼ 10.26, P50.0001), age (F 6,78 ¼ 2.56, P ¼ 0.0258), and the interaction of injection and age (F 12,78 ¼ 1.98, P ¼ 0.0370). In particular, levels of vitellogenin mRNA were reduced approximately 35-fold (F 2,48 ¼ 16.81, P50.0001) and hexamerin-90 mRNA levels were reduced approximately four-fold (F 2,48 ¼ 7.83, P ¼ 0.0054) upon their respective RNAi treatments. Further, levels of vitellogenin mRNA were affected by age (F 3,47 ¼ 5.46, P ¼ 0.0031), with higher levels at 19 days than at any other sampling point. In contrast, levels of hexamerin-90 mRNA were not affected by age (F 3,47 ¼ 0.45, P ¼ 0.7163). The interaction of injection and age was significant for vitellogenin mRNA (F 6,44 ¼ 3.08, P ¼ 0.0145), mostly because levels remained low upon vitellogenin RNAi but peaked at 19 days upon treatment with hexamerin-90 RNAi or buffer. The interaction was not significant for hexamerin-90 mRNA (F 6,44 ¼ 1.14, P ¼ 0.3579).
Because they are two related indices of reproductive proteins, ovarian mass and levels of hemolymph vitellogenin were analyzed by a single two-way MANOVA (Fig. 2) Wet ovarian masses and circulating vitellogenin levels upon RNAi treatments were measured in lubber grasshoppers to assess the effects on normal reproductive physiology. Ovarian masses of grasshoppers treated with vitellogenin RNAi were decreased significantly as of 19 days of age, compared with both control groups. Circulating vitellogenin levels were, surprisingly, increased in individuals treated with vitellogenin RNAi, likely due to a lack of uptake into the developing ovaries. Letters above error bars indicate significant differences within an age cohort. 
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To incorporate the relative contribution both of ovarian growth and of vitellogenin levels in reproductive investment, we estimated the total content of reproductive protein for each individual. We assumed that the largest ovarian masses (i.e., 4000 wet mg), which had full size oocytes needing only to be chorionated before oviposition, would result in a large clutch of 55 eggs (see Drewry et al. 2011) . Hence, each gram of ovary was estimated to contain 13.75 egg equivalents of vitellin. As described in the ''Materials and Methods'' section, previous studies have shown that each mature egg contains approximately 7 dry mg of vitellin (Moehrlin and Juliano 1998; Hatle et al. 2008) , so this was multiplied by the estimated number of egg equivalents for each individual's ovary to yield the total vitellin for that grasshopper. Next, the concentration of hemolymph was multiplied by the previously estimated hemolymph volume of 2.25 mL (further increased by 25% for vitellogenin RNAi individuals: see ''Materials and Methods'' section) to yield the total amount of vitellogenin per individual. The final estimate of the total reproductive protein was the sum of total vitellin and total vitellogenin for that individual. Two-way ANOVA showed an overall effect (F 11,98 ¼ 2.91, P ¼ 0.0026). Total reproductive protein rose with advancing age (F 3,95 ¼ 9.28, P50.0001), but remarkably was not affected by injection (F 2,96 ¼ 0.42, P ¼ 0.6593) or interaction (F 6,92 ¼ 0.70, P ¼ 0.6538).
The mass of the fat body is an index of storage, and two-way ANOVA revealed an overall effect ( Fig. 3; F 11 ,98 ¼ 13.10, P50.0001). Specifically, fat body mass was strongly affected by injection (F 2,96 ¼ 52.02, P50.0001) with vitellogenin RNAi increasing mass, affected slightly less by age (F 3,95 ¼ 3.74, P ¼ 0.0140) with a peak at 19 days, and affected by the interaction of injection and age (F 6,92 ¼ 5.62, P50.0001). In general, mass of the fat body increased with age upon injection of vitellogenin RNAi but did not change with age upon administering Hex-90 RNAi or buffer.
The content of all three hexameric storage proteins was analyzed in a single two-way MANOVA (Fig. 4) . There was no effect of injection (F 6,160 ¼ 1.22, P ¼ 0.2988), a marginal effect of age (F 9,243 ¼ 1.82, P ¼ 0.0644), and no effect of interaction (F 18,243 ¼ 0.70, P ¼ 0.8125). Hexamerin-90 levels were five-fold lower upon treatment with Hex-90 RNAi, but due to high levels of variability, this was not significant (F 2,90 ¼ 2.57, P ¼ 0.0825). To further probe the possibility of the effects of RNAi on hexamerin-90 levels, we combined the treatments of vitellogenin RNAi and buffer and compared this combination against the treatment with Hex-90 RNAi, using a one-way ANOVA. This produced an overall effect (F 7,92 ¼ 2.20, P ¼ 0.0418). The result was due only to a significant effect of injection (F 1,91 ¼ 5.20, P ¼ 0.0250), and not to age (F 3,89 ¼ 1.14, P ¼ 0.3378) or interaction (F 3,89 ¼ 0.86, P ¼ 0.4644). Taken together, this suggests that Hex-90 RNAi often had a large effect on the levels of hexamerin-90 protein, but this was highly variable. Hemolymph ecdysteroids were also quantified to determine whether the ovary of individuals injected with vitellogenin RNAi was functional as an endocrine organ. Previous work has shown that ecdysteroids are produced by the ovary and present only during an approximately 4-day period about 2 weeks before oviposition (Hatle et al. 2003b) . Hence, only samples collected on days 19 and 26 were tested for ecdysteroids, and all samples were tested independently because each individual had a sample for only one of the two dates. Because the samples were only collected every 7th day, it would be expected that certain ecdysteroid peaks would be missed, even for individuals producing the steroid. Thus, we tested whether the treatment groups differed in the number of individuals in which ecdysteroids were detected, as well as comparing ecdysteroid titers directly. There was no effect of injection on ecdysteroid levels (one-way ANOVA, F 2,47 ¼ 0.88, P ¼ 0.4235; Fig. 5 ), but this is not surprising considering detection error. Of the 13 individuals injected with vitellogenin RNAi, three had detectable ecdysteroids in each of two separate assays (detection minimum mean AE SE ¼ 32.8 AE 3.4 pg/mL).
This ratio of detectable to injected was not significantly different from either buffer-injected or Hex-90 RNAi-injected grasshoppers ( 2 ¼ 0.503, df ¼ 1, critical value ¼ 3.84).
To further explore our unexpected effects of vitellogenin knockdown, in Experiment 2 we tested a second dsRNA against vitellogenin (viz 661 bp Vg RNAi) on reproductive tactics. Test solutions were injected after the first oviposition. There were minimal effects on the second clutch, not surprising considering that nutrients allocated to the second clutch are partly sequestered at the time of first oviposition. However, analysis of effects on the third clutch revealed a marginal reduction in number of eggs (oneway MANOVA, F 3,18 ¼ 3.14, P ¼ 0.0566), a highly significant reduction in the length of each egg ( Fig. 6 ; F 3,18 ¼ 12.72, P ¼ 0.0002), and a significant increase in the duration from clutch 2 to clutch 3 (F 3,18 ¼ 7.33, P ¼ 0.0030). In particular, treatment with 661 bp vitellogenin RNAi significantly reduced the size of eggs in comparison both to buffer-injection (P ¼ 0.0023) and to Hex-90 RNAi (P ¼ 0.0038). Further, treatment with 661 bp vitellogenin RNAi significantly increased the duration of clutch 3 upon buffer-injection (P ¼ 0.0275), but not upon injection with Hex-90 RNAi (P ¼ 0.1011). In contrast, the 661 bp vitellogenin RNAi did not affect the number of eggs produced. These results, in conjunction with the mRNA data, clearly support the conclusion that our RNAi treatments affect reproduction.
Experiment 3 had the same design as Experiment 1 (i.e., injection of buffer, Hex-90 RNAi, and vitellogenin RNAi [515 bp]). We measured vitellogenin synthesis in vitro at days 19 and 26. Our goal was to determine whether vitellogenin continued to be Mean egg size of the third clutch and clutch interval (period between second and third clutch) in lubber grasshoppers injected after first oviposition, upon RNAi injections. Overall, the duration of the clutch interval was extended, and egg size was significantly reduced in both Vg RNAi treatment groups. Letters above error bars indicate significant differences within a reproductive tactic (e.g., egg size). Vitellogenin RNAi in young grasshoppers 937 produced at later ages, or if all the hemolymph vitellogenin present was produced at younger ages. Two-way ANOVA revealed only marginal overall effects ( Fig. 7 ; F 5,36 ¼ 2.21, P ¼ 0.0781). However, these were due entirely to age (F 1,35 ¼ 6.20, P ¼ 0.0183), and not to injection (F 2,34 ¼ 0.99, P ¼ 0.3831) or interaction (F 2,34 ¼ 0.61, P ¼ 0.5474). There was greater production at 19 days than at 26 days across all groups, as in previous experiments .
Discussion
Overall, the results of this study illustrate a reduction of reproduction through treatments with vitellogenin RNAi that directly decrease vitellogenin mRNA but do not decrease levels of vitellogenin protein. When vitellogenin RNAi was injected prior to vitellogenesis, ovarian growth was nearly halted. Injection during the normal reproductive period (i.e., after first oviposition) reduced egg size and increased the interval between clutches. Hence, in two independent experiments, treatment with vitellogenin RNAi drastically reduced reproductive output. These results are not attributable to general effects of RNAi (e.g., Alic et al. 2012) , as a Hex-90 RNAi control altered neither vitellogenin mRNA levels nor reproductive growth. Our results imply that the treatment with vitellogenin RNAi affects either transport of vitellogenin from the hemolymph into the ovary or vitellogenin transcription itself. Treatment with vitellogenin RNAi resulted in animals with little vitellin in the oocytes even though high levels of vitellogenin were in the hemolymph. This phenotype resembles German cockroaches with the vitellogenin receptor knocked down by RNAi (Ciudad et al. 2006) , silkworms with mutations in the vitellogenin receptor (Lin et al. 2013) , and Drosophila mutants with loss of function in the receptor for yolk protein (Schonbaum et al. 1995) . There are some similarities between the sequences for insect vitellogenins and the sequences for insect vitellogenin receptors. BLAST analysis revealed that our 515 bp dsRNA against vitellogenin of lubber grasshoppers matched three separate 11 bp segments of the mRNA coding sequence for the vitellogenin receptor of the cockroach Leucophaea maderae (Tufail and Takeda 2007) . Although this is about half of the 22 bp length of a typical siRNA, there may be some inhibition of gene expression by segments as short as 8 bp (e.g., Jackson and Linsley 2010). Therefore, it is possible that our RNAi constructs designed for use against the vitellogenin gene for the lubber grasshopper may have also had activity against their vitellogenin receptor. Unfortunately, we have not yet cloned the vitellogenin receptor from lubber grasshoppers to test this hypothesis. Regardless of the activity of the vitellogenin receptor, the considerable inhibition of reproductive development in our experiments allows examination of the trade-off between reproduction and storage (Glazier 1999) .
Storage and allocation of protein
Although vitellogenin RNAi nearly stopped deposition of vitellin by reducing ovarian growth, it increased vitellogenin levels in the hemolymph. When we estimated the combination of both vitellogenin circulating in the hemolymph and vitellin sequestered into eggs, our analysis suggested that levels of total reproductive protein were not changed significantly by vitellogenin RNAi. That is, treatment with vitellogenin RNAi did not reduce investment in reproductive protein, only whether the protein was invested into the ovary or was kept circulating in the hemolymph.
The reduction in levels of vitellogenin mRNA, but maintenance of levels of total reproductive protein, suggests there may be regulation at the level of translation or of ovarian uptake. It could be that the production of vitellogenin continues, or perhaps (but not mutually exclusively) all the vitellogenin present in the hemolymph (Fig. 2) was produced before the effect of the injections of vitellogenin RNAi, and the vitellogenin was retained in the hemolymph thereafter. To address this question, we tested the in vitro, mass-specific production of vitellogenin at 19 and 26 days. Surprisingly, vitellogenin RNAi did not change the in vitro rate of production of vitellogenin in comparison to Hex-90 RNAi or to buffer-injection. Even so, vitellogenin production was higher at 19 days than at 26 days, as would be expected developmentally (e.g., Borst et al. 2000) ; this supports the veracity of the dataset. In the context of reduced levels of vitellogenin mRNA, sustained production of vitellogenin by the fat body is consistent with an increase in the rate of translation relative to the number of vitellogenin transcripts present. Indeed, production of vitellogenin by lubber grasshoppers has been shown to be subject to translational regulation, as vitellogenin production plummets after 4 days of starvation whereas levels of vitellogenin mRNA remain unchanged (Fei et al. 2005) . A final possibility is that vitellogenin is produced but then remains in the fat body. Although we did not measure this, it would be inconsistent with reduced levels of vitellogenin mRNA in concert with maintained levels of total reproductive protein.
The locations of total reproductive proteins change upon injection with vitellogenin RNAi, whereas the amounts of total reproductive proteins are altered little. The process that appears to be most affected is the uptake of vitellogenin from the hemolymph into the ovarian follicles. Patency is a two-step process. First, the follicle cells of the ovaries shrink to open conduits between the cells, thereby allowing circulating vitellogenin to make contact with the surface of the oocytes (Abu-Hakima and Davey 1977). Second, vitellogenin is taken up from the hemolymph into the oocyte by receptor-mediated endocytosis involving the vitellogenin receptor, a member of the family of low-density lipoprotein receptors (Raikhel and Dhadialla 1992; Tufail and Takeda 2009) . Our results are consistent with blockage of the second step, that is, preventing vitellogenin from moving into the ovaries but instead accumulating in the hemolymph.
Patency is regulated by JH (Chapman 1998) . We quantified JH levels from these animals, but there was no detectable effect of vitellogenin RNAi on JH levels ( Supplementary Fig. S1 ). Previous work suggests that tracking JH levels throughout the oviposition cycle of an individual is critical for identifying changes, as absolute levels vary greatly from one individual to the next, but the typical pattern is highly consistent across individuals . Hence, the lack of significant effect found here is not surprising due to the sampling approach (i.e., only a single sample from each individual).
These results on protein redirection upon experimental reduction of reproduction are somewhat counter to a simple view of the model of the trade-off between reproduction and longevity. A straightforward view of the model would predict that blocking reproduction would result in an increase of hexameric storage proteins, as this is the insect depot for amino acids. However, vitellogenin RNAi did not affect levels of any of the three hexamerins. Instead, we observed reproductive proteins (in the form of vitellogenin) accumulating in the hemolymph. Indeed, the difference in levels of vitellogenin between the vitellogenin RNAi group and the controls increased throughout the course of the experiment, only becoming significant (within an age group) at the final sampling date. From the present data, there is no evidence of even a trend toward increased somatic investment of proteins. This experiment used young grasshoppers, ending at 33 days, just prior to first oviposition. In the laboratory, lubber grasshoppers can lay over 10 clutches and have a median lifespan of 245 days . It may be that this investment in vitellogenin would shift to somatic proteins in older grasshoppers, allowing and increase in lifespan. Future experiments will examine the effect of vitellogenin RNAi on lifespan and protein investment in older grasshoppers.
Storage and allocation of lipids
Knockdown of vitellogenin mRNA had large effects on investment in Iipids. Mass of the fat body was doubled upon treatment with vitellogenin RNAi, consistent with a trade-off between reproduction and storage. The fat body is the primary depot for lipid and carbohydrate in insects (e.g., Chapman 1998), so our results imply that organismal storage of both of these macronutrients was increased. Eggs, and therefore mature oocytes, are about half protein and half lipid (e.g., Chapman 1998). By halting ovarian growth via vitellogenin RNAi, a major deposition of lipid is blocked (cf. Fig. 3 and top panel of Fig. 2) .
Unfortunately, we did not analyze the macronutrient composition of fat bodies. However, calculations can be used to estimate whether lipids were reduced or diverted to a new location. At 33 days, the masses of the fat bodies in individuals treated with vitellogenin RNAi were about 250 wet mg greater than those of controls. Estimates vary for conversions from wet adipose mass to dry adipose mass, but a typical estimate seems to be that adipose consists of 40% water (Baker 1969) , and this is in good agreement with comparisons of dry and wet fat body masses across our past experiments with lubber grasshoppers (cf. this article and Hatle et al. 2005) . Hence, the typical increase in fat body lipid of 250 wet mg converts to about 150 dry mg of lipid. This suggests that, upon treatment with vitellogenin RNAi, about 60% of the lipid that would have accumulated in the ovary is diverted to the fat body. This reduction in Vitellogenin RNAi in young grasshoppers 939 investment of lipid to reproduction is unexpectedly similar to the increase in lipid to storage. It supports the notion that vitellogenin RNAi primarily shifts lipid investment, and only slightly reduces the absolute amount of lipid in the two organs (i.e., the ovary and the fat body). An advantage of physiological manipulation via RNAi, as opposed to classical surgical removal of endocrine organs, is that endocrine signaling presumably remains intact upon RNAi. However, the possibility remains that knocking down a transcript via RNAi secondarily affects signaling of a hormone involved in related processes. To begin to address this, we measured ecdysteroids in the hemolymph. Ecdysteroids are not directly involved in vitellogenesis in lubber grasshoppers. They are produced by the ovary (ecdysteroids are absent from ovariectomized females) and found at high levels for an approximately 4-day period about 2 weeks before oviposition (Hatle et al. 2003b) . Hence, the presence of ecdysteroids can indicate whether the ovary is still functioning as an endocrine organ and also can indicate the timing of its development. Surprisingly, upon RNAi against vitellogenin, hemolymph ecdysteroids were not significantly different from ecdysteroids upon RNAi against Hex-90 or injection of buffer. Although levels of ecdysteroids observed in these animals were low and warrant retesting, the present data suggest that RNAi halting of ovarian growth does not affect ovarian development as an endocrine organ.
The protein and lipid results of our vitellogenin RNAi treatment are similar to ovariectomy in young grasshoppers (Hatle et al. 2008 (Hatle et al. , 2013 . Upon ovariectomy, vitellogenin continues to be produced by the fat body but has nowhere to go, so vitellogenin in the hemolymph accumulates to high levels. By age 40 days (the age of first oviposition in intact individuals), grasshoppers have levels of total reproductive proteins (i.e., hemolymph vitellogenin plus ovarian vitellin) that are similar to intact controls. Thereafter (i.e., 50-150 days), levels of total reproductive proteins decrease and levels of storage proteins increase (Hatle et al. 2008) . We hypothesize that females treated with vitellogenin RNAi, as they get older, will decrease reproductive investment, increase protein storage, and extend lifespan.
